Finally, Scl70 antigen added to sera from five different Scl70 + SSc patients led to a dose-dependent activation of NK cells as measured by increased CD69 expression levels, but not B cells that lack activating Fc receptors such as CD16 (Fig. 3c). The gene discussed is CD69; the disease is systemic sclerosis.